Preface content

A Gene Expression Signature for RSV: Clinical Implications and Limitations

Peter Openshaw discusses the challenges in advancing respiratory syncytial virus (RSV) treatments and the implications of a study by Mejias and colleagues using a newly identified gene signature for diagnosis and prediction of RSV severity. Please see later in the article for the Editors' Summary.

Call to action content

Newsletter

Trim content

Copyright: The Pirbright Institute 2014-2019 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.

 

Site by Lightflows